Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SAREUM S
No Price
Closing Price XLON 01.05.2026:
19,75 GBX
01.05.2026 13:09
Current Prices from SAREUM S
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
London
SAR.L
GBX
01.05.2026 13:09
19,75 GBX
-0,75 GBX
-3,66 %
Share Float & Liquidity
Free Float95,81 %
Shares Float132,28 M
Shares Outstanding138,07 M
Company Profile for SAREUM S Share
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.
